Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare To Expand Cochlear Coverage, Stops Short Of Requested Scope

This article was originally published in The Gray Sheet

Executive Summary

CMS is willing to expand cochlear implant coverage for Medicare beneficiaries, but undershoots Cochlear Americas' full coverage request

You may also be interested in...



MedCAC Seeks Additional Evidence On Cochlear Implants In The Elderly

CMS needs better evidence to inform future coverage policy for cochlear implants, according to the Medicare Evidence Development and Coverage Advisory Committee convening in Baltimore May 11.

MedCAC Seeks Additional Evidence On Cochlear Implants In The Elderly

CMS needs better evidence to inform future coverage policy for cochlear implants, according to the Medicare Evidence Development and Coverage Advisory Committee convening in Baltimore May 11.

CMS expands cochlear implant coverage

Medicare will cover cochlear implants for patients with bilateral pre- or postlinguistic, sensorineural, moderate-to-profound hearing loss, who demonstrate limited benefit from amplification, according to an April 4 final decision memo. "Limited benefit" is defined by test scores of less than 40% correct on a sentence recognition test administered in the patient's best-aided listening condition. The decision is identical to the proposed decision, released in January (1"The Gray Sheet" Jan. 17, 2005, p. 17)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021458

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel